✦ LIBER ✦

Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non–small cell lung cancer

✍ Scribed by Branislav Jeremic; Stanisa Jevremovic; Ljiljana Mijatovic; Slobodan Milisavljevic

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 478 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930601)71:11<3732::aid-cncr2820711142>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double alkylating agent therapy with ifo

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group

✍ Nick Thatcher; David B. Smith; Mike J. Lind; Heather Anderson; Joyce Barclay; Ma 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

Symptomatic treatment versus combination

Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer

✍ Stein Kaasa; Eiliv Lund; Erik Thorud; Reidulv Hatlevoll; Herman Høst 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Pilot study of accelerated hyperfraction

Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma

✍ Jeffrey S. Brindle; Edward G. Shaw; John Q. Su; James A. Mailliard; Albert R. Fr 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

High-dose, multiple-alkylator chemothera

High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer

✍ Stephanie F. Williams; Jacob D. Bitran; Philip C. Hoffman; Erwin Robin; Laura Fu 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 2 views

Phase II trial of a 75-mg/m2 dose of doc

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3

Combination chemotherapy with and withou

Combination chemotherapy with and without the methanol-extracted residue of bacillus calmette-guerin (MER) in extensive non-small-cell lung cancer: A prospective randomized study for the piedmont oncology association

✍ Frederick Richards II; Virginia Howard; Anita Shore; Hyman B. Muss; Douglas R. W 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A